Clinical Trial Detail

NCT ID NCT04042480
Title A Study of SGN-CD228A in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

lung non-small cell carcinoma

colorectal cancer

malignant pleural mesothelioma

skin melanoma

Her2-receptor negative breast cancer

pancreatic ductal adenocarcinoma

Therapies

SGN-CD228A

Age Groups: adult senior

No variant requirements are available.